Seres Therapeutics
MCRB
MCRB
113 hedge funds and large institutions have $2.42B invested in Seres Therapeutics in 2020 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 40 increasing their positions, 30 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
33% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 30
22% more funds holding
Funds holding: 93 → 113 (+20)
0.05% less ownership
Funds ownership: 4.96% → 4.91% (-0.05%)
Holders
113
Holding in Top 10
3
Calls
$83.3M
Puts
$19.3M
Top Buyers
| 1 | +$141M | |
| 2 | +$134M | |
| 3 | +$87.2M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$54.2M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$49.9M |
Top Sellers
| 1 | -$52.9M | |
| 2 | -$51.4M | |
| 3 | -$28.8M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$20.9M |
| 5 |
D.E. Shaw & Co
New York
|
-$8.98M |